-
WHEN THE TAIL WAGS THE DOG - AND WHEN A POPULATION FLOOR REINS IT IN: EXTRAPOLATION TRANSPARENCY AND RELATIVE SURVIVAL ACROSS FIVE ONCOLOGY TRIALS
Aug 11, 2026, 17:16 PM -
EARLY ECONOMIC EVALUATION OF 1VIEW FOR MECHANICAL THROMBECTOMY: A COST-CONSEQUENCE ANALYSIS
Aug 11, 2026, 17:16 PM -
MULTI-COUNTRY CONTENT VALIDATION OF THE EQ-5D-5L + 4 BOLT-ON ITEMS WITHIN NON-SEGMENTAL VITILIGO
Aug 11, 2026, 17:16 PM -
MEASURING TRANSPARENCY AND EQUITY IN PHARMACEUTICAL SYSTEMS: A SCOPING REVIEW OF CONCEPTS, INDICATORS, AND MEASUREMENT APPROACHES
Aug 11, 2026, 17:16 PM -
RESTRICTIVE PRESCRIBING CRITERIA: A SCOPING REVIEW OF MECHANISMS, DRIVERS, AND IMPACTS
Aug 11, 2026, 17:16 PM -
MODELING TIME TOXICITY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A COMPARATIVE ANALYSIS OF TREATMENT-RELATED PATIENT BURDEN
Aug 11, 2026, 17:16 PM -
THE CURRENT STATUS AND GLOBAL RESEARCH ON REAL-WORLD EVIDENCE IN ONCOLOGY CARE PATHWAYS 2010-2024: A BIBLIOMETRIC ANALYSIS
Aug 11, 2026, 17:16 PM -
RISK FACTOR AND PREDICTION OF IN-HOSPITAL MORTALITY FOLLOWING COLORECTAL CANCER SURGERY: A NATIONAL INPATIENT SAMPLE STUDY
Aug 11, 2026, 17:16 PM -
ANTIBIOTIC EXPENDITURE AMONG HOSPITALIZED PATIENTS USING THE WORLD HEALTH ORGANIZATION AWARE CLASSIFICATION IN TUNISIA
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG INTRAVENOUS IRON USERS: A REAL-WORLD COMPARISON BETWEEN PATIENTS WITH AND WITHOUT CONCOMITANT HEMOTHERAPY IN A BRAZILIAN HEALTH PLAN
Aug 11, 2026, 17:16 PM -
SURROGATE ENDPOINTS, CLINICAL UNCERTAINTY, AND REAL-WORLD DECISION-MAKING: LESSONS FROM HB-HTA OF TOFERSEN IN AMYOTROPHIC LATERAL SCLEROSIS
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF SCREENING FOR PRIMARY ALDOSTERONISM IN PATIENTS WITH HYPERTENSION ACROSS MULTIPLE COUNTRIES
Aug 11, 2026, 17:16 PM -
FORECASTING UK BRANDED MEDICINES SPEND UNDER VPAG: A MACHINE-LEARNING MODEL INTEGRATING NHS PRESCRIBING AND COMMERCIAL SALES DATA
Aug 11, 2026, 17:16 PM -
BRIDGING EUROPEAN AND NATIONAL HTA: IMPLEMENTATION OF JOINT CLINICAL ASSESSMENTS ACROSS EU MEMBER STATES
Aug 11, 2026, 17:16 PM -
EXPLORING THE FUTURE TREATMENT LANDSCAPE OF RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): HOW CLINICAL TRIAL LINE OF THERAPY (LOT) ELIGIBILITY MAY RESHAPE TREATMENT SEQUENCING
Aug 11, 2026, 17:16 PM -
FROM EVIDENCE TO ACCESS: REIMBURSEMENT AND FUNDING BARRIERS FOR INNOVATIVE PERIPHERAL NEUROPATHIC PAIN TREATMENTS IN SOUTH KOREA
Aug 11, 2026, 17:16 PM -
THE DIFFERENCE MATTERS (EVEN WHEN IT'S NULL): A PRACTICAL FRAMEWORK FOR SEX- AND AGE-STRATIFIED RWE
Aug 11, 2026, 17:16 PM -
A LONGITUDINAL COMPARISON OF THE 2014 AND 2018 CHINESE EQ-5D-3L VALUE SETS IN PATIENTS WITH ACUTE ISCHEMIC STROKE: FINDINGS FROM THE CASTOR STUDY
Aug 11, 2026, 17:16 PM -
FLEXIBLE PARAMETRIC NON-MIXTURE CURE MODELS: A PROPOSED GUIDE FOR USE AND IMPLEMENTATION IN HEALTH TECHNOLOGY APPRAISALS
Aug 11, 2026, 17:16 PM -
OBESITY AND WORKPLACE PRODUCTIVITY IN EUROPE: A TARGETED REVIEW OF THE EVIDENCE BASE FOR HEALTH ECONOMIC MODELING
Aug 11, 2026, 17:16 PM
